Kyle M. Rose, MD

Kyle M. Rose, MD, Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center & Research Institute

Articles by Kyle M. Rose, MD

Roger Li, MDNon-Muscle Invasive Urothelial Carcinoma | December 16, 2024
The panelists share their insights on risk assessment, and customized treatment strategies for high-risk NMIBC.
Roger Li, MDNon-Muscle Invasive Urothelial Carcinoma | December 16, 2024
The panelists discuss the evolving landscape of bladder cancer treatments, focusing on balancing bladder-sparing therapies.
Roger Li, MDNon-Muscle Invasive Urothelial Carcinoma | December 16, 2024
The panelists debate the potential of combining intravesical immunotherapy with immune checkpoint inhibitors.
Roger Li, MDNon-Muscle Invasive Urothelial Carcinoma | December 16, 2024
The panelists share their perspectives on SunRISe-1 and the evolving role of TAR-200 in treating BCG-unresponsive UC.
Roger Li, MDNon-Muscle Invasive Urothelial Carcinoma | December 16, 2024
The second segment of this roundtable focuses on the evolving landscape of treatments for BCG-unresponsive bladder cancer.
Roger Li, MDNon-Muscle Invasive Urothelial Carcinoma | December 16, 2024
Part one of this roundtable highlights current practices, emerging therapies, and the future landscape of NMIBC care.
Kyle M. Rose, MDASCO GU Symposium 2023 | February 24, 2023
Kyle M. Rose, MD, describes how cell-free DNA is used to detect MRD prior to repeat-transurethral resection in NMIBC.